Savient Sues More Generic Cos. Over Weight-Gain Drug
Drug manufacturer Savient Pharmaceuticals Inc. has launched a patent infringement suit against Novartis AG unit Sandoz Pharmaceuticals and Upsher-Smith Laboratories Inc. over their generic version of Savient's lucrative weight-gain drug, Oxandrin....To view the full article, register now.
Already a subscriber? Click here to view full article